Binding Mode
ChemicalBook > CAS DataBase List > TPX-0005

TPX-0005

Binding Mode
Product Name
TPX-0005
CAS No.
1802220-02-5
Chemical Name
TPX-0005
Synonyms
Repotrectinib;TPX-005;Ropotrectinib;CS-2479;TPX-0005;Loprotinib;PX0005(Ropotrectinib);TPX0005(Ropotrectinib);Repotrectinib,TPX-0005;TPX-0005,Repotrectinib
CBNumber
CB83312797
Molecular Formula
C18H18FN5O2
Formula Weight
355.37
MOL File
1802220-02-5.mol
More
Less

TPX-0005 Property

Density 
1.46±0.1 g/cm3(Predicted)
storage temp. 
Store at -20°C
solubility 
DMSO:35.0(Max Conc. mg/mL);98.5(Max Conc. mM)
Ethanol:10.0(Max Conc. mg/mL);28.1(Max Conc. mM)
form 
A crystalline solid
pka
10.79±0.60(Predicted)
InChI
InChI=1S/C18H18FN5O2/c1-10-8-20-18(25)14-9-21-24-6-5-16(23-17(14)24)22-11(2)13-7-12(19)3-4-15(13)26-10/h3-7,9-11H,8H2,1-2H3,(H,20,25)(H,22,23)/t10-,11+/m0/s1
InChIKey
FIKPXCOQUIZNHB-WDEREUQCSA-N
SMILES
O1C2=CC=C(F)C=C2[C@@H](C)NC2C=CN3C(N=2)=C(C=N3)C(=O)NC[C@@H]1C
More
Less

Hazard and Precautionary Statements (GHS)

Symbol(GHS)
Signal word
Warning
Hazard statements

H302Harmful if swallowed

H315Causes skin irritation

H319Causes serious eye irritation

H335May cause respiratory irritation

Precautionary statements

P261Avoid breathing dust/fume/gas/mist/vapours/spray.

P305+P351+P338IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing.

More
Less

N-Bromosuccinimide Price

Cayman Chemical
Product number
23397
Product name
TPX-0005
Purity
≥98%
Packaging
1mg
Price
$32
Updated
2024/03/01
Cayman Chemical
Product number
23397
Product name
TPX-0005
Purity
≥98%
Packaging
5mg
Price
$139
Updated
2024/03/01
Cayman Chemical
Product number
23397
Product name
TPX-0005
Purity
≥98%
Packaging
10mg
Price
$243
Updated
2024/03/01
Cayman Chemical
Product number
23397
Product name
TPX-0005
Purity
≥98%
Packaging
25mg
Price
$533
Updated
2024/03/01
ChemScene
Product number
CS-7628
Product name
Repotrectinib
Purity
99.81%
Packaging
50mg
Price
$590
Updated
2021/12/16
More
Less

TPX-0005 Chemical Properties,Usage,Production

Binding Mode

The cocrystal structures of repotrectinib with TRK proteins are yet to be reported. However, a docking model with TRKA suggests that the pyrazole nitrogen forms hydrogen bonds with Met592 in the hinge area. The fluorophenyl group, positioned in a hydrophobic pocket, aligns perpendicularly to the macrocycle, and the lactam oxygen atom engages in a water-mediated hydrogen bond with Met592 in the hinge region (Figs. 1,2).

Description

Ropotrectinib (TPX-0005; TP Therapeutics, San Diego, CA, USA) is a nextgeneration ROS1 inhibitor, a novel three-dimensional macrocyle with a much smaller size (MW <370) than current ROS1 inhibitors. It was specifically designed to overcome resistance mutations. Preclinical studies have shown activity against gatekeeper and solvent mutations, including G2032R, D2033N, L2026M, S1986F/Y, L1951R, and kinases involved in bypass signaling such as focal adhesion kinase, SRC proto-oncogene, and non-receptor tyrosine kinase [102, 103].

Description

Repotrectinib, also known as TPX-0005, is a multikinase (ROS1, ALK, and TRKA/B/C) inhibitor that is tested in an ongoing first-in-human phase 1/2 trail (NCT03093116).

General Description

Class: receptor tyrosine kinase; Treatment: NSCLC; Other name: TPX-0005

Biological Activity

Repotrectinib is a potent inhibitor targeting solvent-front mutations (SFMs) of ROS1, pan-TRK, and ALK. It effectively inhibits the kinase activity of wild-type ROS1, TRKA-C, and ALK, along with their SFMs, with IC50 values ranging from 0.071 to 4.46 nM. The compound shows high potency against ROS1 and TRKA-C, with approximately 15-fold selectivity over ALK.

Clinical Use

Repotrectinib has advantage with central nervous system (CNS) penetration, aimed to target both wide-type (WT) and solvent-front mutations (SFM) kinases and other resistance mutations including ROS1-G2032R and ROS1-D2033N, TRKA-G595R, TRKB-G639R, TRKC-G623R, and ALK-G1202R.

target

Primary targets: NTRK, ROS, ALT

TPX-0005 Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

TPX-0005 Suppliers

Shanghai Hope Chem Co., Ltd.,
Tel
+21-18501659228 18501659228
Fax
sales@hope-chem.com
Email
info@hope-chem.com
Country
China
ProdList
438
Advantage
55
Anqing Benro pharmachem Technology Co.,Ltd.
Tel
05565209906 15391842992
Email
794263564@qq.com
Country
China
ProdList
114
Advantage
58
Chunchuang (Wuhan) Technology Co., Ltd
Tel
15342225168
Email
yutianchun2007@126.com
Country
China
ProdList
10008
Advantage
58
ShangHai Caerulum Pharma Discovery Co., Ltd.
Tel
18149758185
Email
sales-cpd@caerulumpharma.com
Country
China
ProdList
3429
Advantage
58
HANGZHOU KELAI BIOMEDICAL TECHNOLOGY Co., Ltd.
Tel
18957050573
Email
752803249@qq.com
Country
China
ProdList
244
Advantage
58
Suzhou Ryan Pharmaceutical Technology Co., Ltd.
Tel
0512-68780025,68780026 18962125825
Email
sales@ryanchem.com
Country
China
ProdList
161
Advantage
62
Suzhou Albertchem Co.,Ltd.
Tel
0512-88968486 18012631750
Email
sales@albertchemical.com
Country
China
ProdList
268
Advantage
58
Beijing Zhongshuo Pharmaceutical Technology Development Co., Ltd
Tel
010-53679529 13801208576
Fax
010-64215766
Email
sales.2@chinazhongshuo.com
Country
China
ProdList
98
Advantage
65
BOC Sciences
Tel
1-631-485-4226; 16314854226
Email
info@bocsci.com
Country
United States
ProdList
14059
Advantage
65
MedChemexpress LLC
Tel
021-58955995
Fax
609-228-5909
Email
sales@medchemexpress.cn
Country
United States
ProdList
4863
Advantage
58
More
Less

View Lastest Price from TPX-0005 manufacturers

Jinan Million Pharmaceutical Co., Ltd
Product
Repotrectinib/TPX-0005 1802220-02-5
Price
US $2.00/kg
Min. Order
1kg
Purity
99%
Supply Ability
50KG/M
Release date
2023-08-14
Nanjing Fred Technology Co., Ltd
Product
Repotrectinib 1802220-02-5
Price
US $0.00-0.00/kg
Min. Order
1kg
Purity
99%, Single impurity<0.1
Supply Ability
1 ton
Release date
2023-12-20
Hebei Yanxi Chemical Co., Ltd.
Product
TPX-0005 1802220-02-5
Price
US $50.00/kg
Min. Order
1kg
Purity
0.99
Supply Ability
10000
Release date
2023-11-16

1802220-02-5, TPX-0005Related Search:


  • Ropotrectinib
  • TPX-0005;TPX 0005;TPX0005
  • CS-2479
  • Repotrectinib(TPX-005)
  • Repotrectinib
  • Repotrectinib,TPX-0005
  • TPX-0005
  • 1,15-Etheno-1H-pyrazolo[4,3-f][1,4,8,10]benzoxatriazacyclotridecin-4(5H)-one,11-fluoro-6,7,13,14-tetrahydro-7,13-dimethyl-, (7S,13R)-
  • TPX-0005,Repotrectinib
  • TPX-005
  • TPX0005(Ropotrectinib)
  • Ropotrectinib(TPX0005)
  • Loprotinib
  • (7S,13R)-11-Fluoro-6,7,13,14-tetrahydro-7,13-dimethyl-1,15-etheno-1H-pyrazolo[4,3-f][1,4,8,10]benzoxatriazacyclotridecin-4(5H)-one
  • PX0005(Ropotrectinib)
  • 1802220-02-5
  • 180222-02-5
  • API
  • 1802220-02-5